Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$690M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$520M |
| 3 |
Booking.com
BKNG
|
+$346M |
| 4 |
QuantumScape Corp
QS
|
+$327M |
| 5 |
L3Harris
LHX
|
+$312M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DNKN
Dunkin' Brands Group, Inc.
DNKN
|
+$476M |
| 2 |
Home Depot
HD
|
+$470M |
| 3 |
Intuitive Surgical
ISRG
|
+$427M |
| 4 |
Salesforce
CRM
|
+$383M |
| 5 |
Intel
INTC
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.01% |
| 2 | Healthcare | 19.61% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Financials | 9.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATVI
101
DELISTED
Activision Blizzard
ATVI
| $503M | 0.23% |
5,417,629
+2,923,884
| +117% | +$237M |
|
102
Ascendis Pharma A/S
ASND
$16.7B
| $502M | 0.23% |
3,008,829
+42,223
| +1% | +$6.98M |
|
103
BioMarin Pharmaceuticals
BMRN
$12B
| $499M | 0.23% |
5,686,942
+472,232
| +9% | +$37.4M |
|
|
SEE
104
DELISTED
Sealed Air
SEE
| $487M | 0.23% |
10,628,522
+1,373,044
| +15% | +$59.5M |
|
105
Match Group
MTCH
$9.16B
| $486M | 0.23% |
3,212,798
-201,008
| -6% | -$26.6M |
|
106
Amdocs
DOX
$5.83B
| $482M | 0.22% |
6,802,093
-8,377
| -0.1% | -$526K |
|
107
Dentsply Sirona
XRAY
$2.7B
| $482M | 0.22% |
9,206,575
+953,367
| +12% | +$47M |
|
108
Starbucks
SBUX
$118B
| $470M | 0.22% |
4,393,040
+410,211
| +10% | +$39.2M |
|
109
Revvity
RVTY
$12.4B
| $464M | 0.22% |
3,230,569
-539,557
| -14% | -$71.8M |
|
110
Target
TGT
$65.5B
| $462M | 0.21% |
2,615,294
+87,053
| +3% | +$14.5M |
|
111
RingCentral
RNG
$4.77B
| $460M | 0.21% |
1,212,726
+184,112
| +18% | +$57.3M |
|
112
Equinix
EQIX
$102B
| $459M | 0.21% |
643,416
+106,995
| +20% | +$79.6M |
|
113
Dollar General
DG
$27.8B
| $454M | 0.21% |
2,161,055
+104,285
| +5% | +$22.3M |
|
114
Bank of America
BAC
$439B
| $444M | 0.21% |
14,636,465
+759,741
| +5% | +$20.4M |
|
115
Novartis
NVS
$304B
| $441M | 0.2% |
4,669,601
+29,894
| +0.6% | +$2.61M |
|
116
Zurn Elkay Water Solutions
ZWS
$8.23B
| $440M | 0.2% |
23,123,422
-254,682
| -1% | -$4.37M |
|
117
W.R. Berkley
WRB
$28.3B
| $439M | 0.2% |
14,858,512
-82,030
| -0.5% | -$2.37M |
|
|
XLNX
118
DELISTED
Xilinx Inc
XLNX
| $437M | 0.2% |
3,084,088
-2,394,635
| -44% | -$311M |
|
119
Alliant Energy
LNT
$19.1B
| $437M | 0.2% |
8,473,743
+2,581,492
| +44% | +$139M |
|
120
RB Global
RBA
$21.7B
| $435M | 0.2% |
6,257,925
+9,856
| +0.2% | +$652K |
|
121
Corning
GLW
$108B
| $431M | 0.2% |
11,980,099
+78,417
| +0.7% | +$2.79M |
|
122
Monster Beverage
MNST
$95.6B
| $431M | 0.2% |
9,319,644
+1,158
| +0% | +$48.7K |
|
123
Ingersoll Rand
IR
$33.9B
| $427M | 0.2% |
9,362,272
-343,024
| -4% | -$14.2M |
|
|
ALXN
124
DELISTED
Alexion Pharmaceuticals
ALXN
| $421M | 0.2% |
2,697,186
+1,149,833
| +74% | +$148M |
|
125
Globus Medical
GMED
$10.9B
| $420M | 0.2% |
6,441,759
+86,833
| +1% | +$4.99M |
|
Similar funds
Janus Henderson Group's Q4 2020 Portfolio in Review
As of Q4 2020, Janus Henderson Group held 1,466 positions worth $215B, up 12% from $192B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group's Q4 2020 filing shows 149 new, 548 increased, 655 reduced and 89 closed positions. Its largest new stake was DoorDash: 1,217,110 shares worth $174M. The largest sale was Dunkin' Brands Group, Inc., an estimated $476M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2020 buy was DoorDash: 1,217,110 shares worth $174M.
- Janus Henderson Group added most to Illumina in Q4 2020, an estimated $690M increase.
- Janus Henderson Group's biggest Q4 2020 reduction was Home Depot, cutting an estimated $470M.
- Janus Henderson Group fully exited Dunkin' Brands Group, Inc. in Q4 2020, selling an estimated $476M.
- Janus Henderson Group's ten largest holdings make up 22% of its $215B portfolio in Q4 2020.
- Janus Henderson Group opened 149 new positions and closed 89 in Q4 2020.
- Janus Henderson Group's portfolio value rose 12% quarter-over-quarter to $215B.
Based on Janus Henderson Group's 13F filing for Q4 2020, filed 16 Feb 2021.